Health & Medicine Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health & Medicine Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antiviral Therapy
Several factors contribute to treatment failure in chronic hepatitis C
September 1st, 2003
Several factors contribute to treatment failure in chronic hepatitis C. "The treatment of chronic hepatitis C is currently based on a combination of pegylated interferon (IFN)-alpha and ribavirin. When successful, this treatment leads to sustained HCV clearance which, in virtually all cases, signifies viral eradication. However, approximately 20% of patients with hepatitis C virus (HCV) genotype 2 or 3 infection, and 50% of patients with genotype 1 infection, fail to eradicate the virus," according to research from France. "The risk of treatment failure is related to multiple factors, including the treatment schedule, adherence of therapy, host...
Source: Health & Medicine Week (2003-09-01)
|
